Skip to content
Screener

Elanco Animal Health Inc. ELAN G&A

G&A at other companies

Neogen logo
NeogenNEOG
$60.3M+8.1%
Balchem logo
BalchemBCPC
$18.48M+18.7%
Lemonade logo
LemonadeLMND
$42.2M+17.5%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$116.82M+18.4%
VAN
Vivani MedicalVANI
$2.43M+3.7%

Segments

By segment

See full
Reportable Segment$139M+8.6%

Other financials

Income statement

See full
Revenue$1.4B+10.2%
Gross profit$798.0M+11.9%
Net income$54.0M+391%
EPS (diluted)$0.11+450%

Balance sheet

See full
Cash & equivalents$530.0M-1.7%
Total debt$4.2B-6.2%
Total equity$6.6B-2.8%
Total assets$13.6B-1.3%

Cash flow

See full
Operating cash flow$277.0M+16.9%
CapEx$33.0M-42.1%
Free cash flow$244.0M+35.6%

Valuation

See full
Market cap$13.1B+89.0%
Enterprise value$16.81B+54.0%
P/S2.6×+1.1×

Profitability

See full
Gross margin55.4%+0.6pp
Net margin-4%-13.8pp
FCF margin7.5%-0.5pp

Returns & leverage

See full
Return on equity-3%-9.9pp
Debt / equity0.6×0.0×
Current ratio2.1×-0.5×

FAQ

What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.